Novomics Co.
Latest round
- Series C
Last raised
- Sep 2018
Total raised
- $22M
Investors
- 6
About Novomics Co.
, Ltd. operates as a developer of molecular diagnostic tests for stage II-III gastric cancer patients. In 2020, it passed China Inspection and Quarantine Certification. The company has developed a molecular diagnostic assay, the nProfiler 1 Stomach Cancer Assay. It is designed to provide prognostic information to clinicians and help determine treatment plans and methods to avoid over- or under-treatment according to the patient's condition.
Who invested in Novomics Co.
6 investors across 3 rounds
See all investors in Novomics Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Novomics Co.
Who invested in Novomics Co.?
Novomics Co. has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Novomics Co. raised?
Novomics Co. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Novomics Co. last raise money?
Novomics Co.'s most recent round on record is a Series C, in Sep 2018.
What does Novomics Co. do?
Novomics Co. is a medical devices & equipment company.
Where is Novomics Co. headquartered?
Novomics Co. is headquartered in Seoul, South Korea.
Which VCs invest in companies like Novomics Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Novomics Co.'s stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series C
Raising like Novomics Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.